Iradimed Corp (IRMD) Q3 2024 Earnings Report - Results, Call & Slides
Iradimed Corp (IRMD) reported its Q3 2024 earnings, beating both EPS and revenue expectations. The company posted an actual EPS of $0.43 against a consensus of $0.41, and actual revenue of $18.33 million against an expected $18.15 million, reflecting an 11.04% year-over-year growth. The …